PRFX logo

PainReform (PRFX)

Profile

Full Name

PainReform Ltd.

Ticker Symbol

PRFX

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Israel

IPO

September 1, 2020

Indexes

Not included

Website

http://www.painreform.com

Employees

2

Key Details

Price

$2.07(-0.48%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$32.16(+49.06% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.07
PRFX price is $2.07

30-Day Relative Volume

0.07
PRFX 30-day relative volume is 0.07

Price Performance

Price Most recent change

-0.48%
PRFX price was down -0.48% on Apr 14, 2025

Price YTD change

-38.3%
PRFX price is down -38.3% since January 1st

Price 1-year change

-68.66%
PRFX price is down -68.66% year-on-year

Price 3-year change

-97.12%
PRFX price is down -97.12% over the past 3 years

Price Range

Price All-time high

$409.20
PRFX price is currently -99.49% below its historical high of $409.20

Price 3-year low

$0.24
PRFX price is currently +769.75% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.90M
PRFX market capitalization is $3.90 million

Market cap 3-year change

+23.73%
PRFX market capitalization is up +23.73% over the past 3 years

Market cap All-time high

$15.00M
PRFX market capitalization is currently -73.99% below its historical high of $15.00 million

Market cap sector rank

10.77%
PRFX market capitalization is higher than 10.77% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2133.41%
PRFX shares outstanding is up +2133.41% year-on-year

Shares Outstanding 3-Year Change

+4203.65%
PRFX shares outstanding is up +4203.65% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.07
PRFX beta is 1.07

200-day SMA

$2.24
PRFX price is currently -7.56% below its 200-day simple moving average

50-day SMA

$2.76
PRFX price is currently -24.89% below its 50-day simple moving average

RSI

39.66
PRFX 14-day relative strength index is 39.66

Volume

0.07
PRFX 30-day relative volume is 0.07

ATR

$0.29
PRFX average true range is $0.29

10-day Historical Volatility

126.03%
PRFX 10-day historical volatility is 126.03%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
PRFX annual revenue value is unknown

Revenue Analysts estimate

-
PRFX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
PRFX annual revenue 1-year change is unknown

Revenue Sector rank

-
PRFX annual revenue is unknown

EPS

EPS

-$32.16
PRFX annual earnings per share is -$32.16

EPS Analysts estimate

-$12.06
PRFX annual earnings per share is currently +166.67% higher than the consensus analysts' forecast

EPS 1-year change

+49.06%
PRFX annual earnings per share is up +49.06% year-on-year

EPS Sector rank

5.04%
PRFX annual earnings per share is higher than 5.04% of companies in Healthcare sector

Profit

Gross profit

-
PRFX annual gross profit value is unknown

Gross margin

-
PRFX annual gross profit margin value is unknown

Operating profit

-$14.67M
PRFX annual operating income is -$14.67 million

Operating margin

-
PRFX annual operating profit margin value is unknown

Net income

-$14.59M
PRFX annual net profit is -$14.59 million

Net margin

-
PRFX annual net profit margin value is unknown

Expenses

Total expenses

$14.67M
PRFX annual total expenses is $14.67 million

Operating expenses

$14.67M
PRFX annual total operating expenses is $14.67 million

Cost of goods sold

-
PRFX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$2.97M
PRFX annual SGA is $2.97 million

Depreciation and amortization

$16.00K
PRFX annual depreciation & amortization is $16.00 thousand

Interest expense

-
PRFX annual interest expense value is unknown

Income tax

$8000.00
PRFX annual income tax is $8000.00

EBIT & EBITDA

EBIT

-$14.67M
PRFX annual earnings before interest & taxes is -$14.67 million

EBITDA

-$14.66M
PRFX annual EBITDA is -$14.66 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.53M
PRFX annual total assets is $4.53 million

Non current assets

$97.00K
PRFX annual long term assets is $97.00 thousand

Current assets

$4.43M
PRFX annual total current assets is $4.43 million

Cash and cash equivalents

$4.26M
PRFX annual cash & cash equivalents is $4.26 million

Accounts receivable

-
PRFX annual accounts receivable value is unknown

Inventory

-
PRFX annual inventory value is unknown

Liabilities

Total liabilities

$2.70M
PRFX annual total liabilities is $2.70 million

Long term liabilities

$259.00K
PRFX annual total long term liabilities is $259.00 thousand

Current liabilities

$2.44M
PRFX annual total current liabilities is $2.44 million

Accounts payable

$296.00K
PRFX annual accounts payable is $296.00 thousand

Debt

Total debt

$45.00K
PRFX annual total debt is $45.00 thousand

Total debt 1-year change

-47.67%
PRFX annual total debt is down -47.67% year-on-year

Long term debt

$0.00
PRFX annual long term debt is $0.00

Short term debt

$45.00K
PRFX annual short term debt is $45.00 thousand

Equity & Capital

Shareholders equity

$1.82M
PRFX annual stockholders equity is $1.82 million

Book value

$1.82M
PRFX annual book value is $1.82 million

Retained earnings

-$56.45M
PRFX annual retained earnings is -$56.45 million

Working capital

$1.99M
PRFX annual working capital is $1.99 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$12.62M
PRFX annual cash flow from operations is -$12.62 million

Cash from operations 1-year change

-88.97%
PRFX annual cash flow from operations is down -88.97% year-on-year

Cash from investing

-$13.00K
PRFX annual cash flow from investing activities is -$13.00 thousand

Cash from investing 1-year change

-100.22%
PRFX annual cash flow from investing activities is down -100.22% year-on-year

Cash from financing

$8.86M
PRFX annual cash flow from financing activities is $8.86 million

Cash from financing 1-year change

+92.01%
PRFX annual cash flow from financing activities is up +92.01% year-on-year

CAPEX

CAPEX

-
PRFX annual capital expenditures value is unknown

CAPEX 1-year change

-
PRFX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$12.63M
PRFX annual free cash flow is -$12.63 million

Free cash flow 1-year change

-88.91%
PRFX annual free cash flow is down -88.91% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
PRFX annual gross profit margin value is unknown

Operating margin

-
PRFX annual operating profit margin value is unknown

Net margin

-
PRFX annual net profit margin value is unknown

ROA & ROE

ROA

-322.39%
PRFX annual return on assets is -322.39%

ROE

-799.78%
PRFX annual return on equity is -799.78%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PRFX price to earnings ratio value is unknown

PE ratio Sector rank

-
PRFX price to earnings ratio is unknown

PB Ratio

PB ratio

-1.91
PRFX price to book ratio is -1.91

PB ratio Sector rank

6.34%
PRFX price to book ratio is higher than 6.34% of companies in Healthcare sector

PS Ratio

PS ratio

-
PRFX price to sales ratio value is unknown

PS ratio Sector rank

-
PRFX price to sales ratio is unknown

Enterprise value

Enterprise value

$1.18M
PRFX enterprise value is $1.18 million

Enterprise value Sector rank

14.63%
PRFX enterprise value is higher than 14.63% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.07
PRFX EV/EBITDA is -0.07

EV/EBITDA Sector rank

62.87%
PRFX EV/EBITDA is higher than 62.87% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.81
PRFX annual current ratio is 1.81

Quick ratio

-
PRFX annual quick ratio value is unknown

Leverage

Debt to equity

0.02
PRFX annual debt to equity ratio is 0.02

Interest coverage ratio

-
PRFX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
PRFX piotroski f-score value is unknown

Altman Z-Score

-
PRFX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Oct 24, 24 Maxim Group
Hold
Jun 26, 24 Maxim Group
Buy

Institutional Ownership

Similar stocks

NUWE logo
Nuwellis (NUWE)
XYLO logo
Xylo Technologies (XYLO)
SNOA logo
Sonoma Pharmaceuticals (SNOA)
CHEK logo
Check-Cap (CHEK)
TCRT logo
Alaunos Therapeutics (TCRT)
AMIX logo
Autonomix Medical (AMIX)
XWEL logo
XWELL (XWEL)
TOVX logo
Theriva Biologics (TOVX)
CNSP logo
CNS Pharmaceuticals (CNSP)
  • What is the ticker symbol for PainReform?
  • Does PainReform pay dividends?
  • What sector is PainReform in?
  • What industry is PainReform in?
  • What country is PainReform based in?
  • When did PainReform go public?
  • Is PainReform in the S&P 500?
  • Is PainReform in the NASDAQ 100?
  • Is PainReform in the Dow Jones?
  • When was PainReform's last earnings report?
  • When does PainReform report earnings?
  • Should I buy PainReform stock now?

What is the ticker symbol for PainReform?

The ticker symbol for PainReform is NASDAQ:PRFX

Does PainReform pay dividends?

No, PainReform does not pay dividends

What sector is PainReform in?

PainReform is in the Healthcare sector

What industry is PainReform in?

PainReform is in the Drug Manufacturers - Specialty & Generic industry

What country is PainReform based in?

PainReform is headquartered in Israel

When did PainReform go public?

PainReform's initial public offering (IPO) was on September 1, 2020

Is PainReform in the S&P 500?

No, PainReform is not included in the S&P 500 index

Is PainReform in the NASDAQ 100?

No, PainReform is not included in the NASDAQ 100 index

Is PainReform in the Dow Jones?

No, PainReform is not included in the Dow Jones index

When was PainReform's last earnings report?

PainReform's most recent earnings report was on Aug 15, 2024

When does PainReform report earnings?

The next expected earnings date for PainReform is May 15, 2025

Should I buy PainReform stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page